Groundbreaking neurostimulation technology offers hope and healing for difficult-to-manage pain. Chronic low back pain, a formidable foe causing disability and soaring healthcare costs, now faces a ...

Add Task & Purpose (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results.

Mainstay Medical Holdings plc has won U.S. FDA approval for its Reactiv8 implantable neurostimulation device. The company is eyeing a commercial launch of the system in early 2021. The FDA approved ...

It was such pain that introduced me to these muscles and started me on a journey that meandered from outer space to the inside of a cell. But let’s start at the beginning. It was just an innocent ...